Five Arrows, the alternative assets arm of Rothschild & Co, has arranged and provided a unitranche facility to support Vivo Capital’s investment in Dutscher Group.
In February, LBO France agreed the sale of Dutscher to the US healthcare and life sciences investment firm. It was Vivo’s first buyout investment in Europe.
Founded in 1982, Dutscher is the European leader in the distribution of consumables and equipment to R&D laboratories, with a catalogue of more than one million products, a client base of over 25,000 customers and employing over 1,100 people. Dutscher generated revenues exceeding €400m in 2025.






